These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 19418390)

  • 21. Formoterol (Foradil Aerolizer) for asthma.
    Med Lett Drugs Ther; 2001 May; 43(1104):39-40. PubMed ID: 11353924
    [No Abstract]   [Full Text] [Related]  

  • 22. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting.
    Lee-Wong M; Chou V; Ogawa Y
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):146-52. PubMed ID: 18320916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of inhaled formoterol in asthma.
    Senn S; Richardson WN; Shaw M
    Respir Med; 1991 Mar; 85(2):169-70. PubMed ID: 1887135
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical efficacy with formoterol in the absence of a response to salmeterol: a review.
    Kottakis J; Wood R; Le Gros V; Della Cioppa G
    Int J Clin Pract; 2001 Sep; 55(7):476-9. PubMed ID: 11594259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
    Ulrik CS; Kok-Jensen A
    Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
    Vogelmeier C; D'Urzo A; Pauwels R; Merino JM; Jaspal M; Boutet S; Naya I; Price D
    Eur Respir J; 2005 Nov; 26(5):819-28. PubMed ID: 16264042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E; FitzGerald JM
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset of action of formoterol versus salmeterol.
    Aalbers R; van der Woude HJ
    Respir Med; 2007 Apr; 101(4):871-2; author reply 873-4. PubMed ID: 17298879
    [No Abstract]   [Full Text] [Related]  

  • 31. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statistics: Salmeterol and asthma].
    Tjørnum TE
    Ugeskr Laeger; 1995 Feb; 157(9):1210. PubMed ID: 7701671
    [No Abstract]   [Full Text] [Related]  

  • 37. [Foradil p (Formoterol)--a new long-acting beta2-sympathomimetic for inhalation].
    Pneumologie; 1997 Feb; 51(2 Suppl):1-8. PubMed ID: 9131836
    [No Abstract]   [Full Text] [Related]  

  • 38. [How compliance is improved. Combined treatment of asthma].
    MMW Fortschr Med; 2001 Oct; 143(42):65. PubMed ID: 11697298
    [No Abstract]   [Full Text] [Related]  

  • 39. Asthma control.
    Connolly CK
    Lancet; 1994 Sep; 344(8924):760. PubMed ID: 7915810
    [No Abstract]   [Full Text] [Related]  

  • 40. Dosage clarification.
    Wickwire T
    AAOHN J; 2005 Mar; 53(3):100; author reply 100. PubMed ID: 15789962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.